Cathie Wood’s ARK Invest Buys Nearly 1.5 Million Shares of Ginkgo Bioworks
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these funds bought roughly $17 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these funds were down sharply on Wednesday.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 485,075 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 995,250 shares. At Wednesday’s closing price, this would have valued the sales at roughly $16.9 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 26% and the other is down 11% in the past year.
Check out all the ARK Invest purchases for Wednesday as well:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | SE | SEA | 25,964 |
| ARKF | TWLO | TWILIO | 25,714 |
| ARKF | TOST | TOAST | 151,274 |
| ARKF | DSYSJ | DISCOVERY | 26,840 |
| ARKG | ONEM | 1LIFE HEALTHCARE | 450,594 |
| ARKG | DNA | GINKGO BIOWORKS | 485,075 |
| ARKG | VCYT | VERACYTE | 70,279 |
| ARKG | SDGR | SCHRODINGER | 78,197 |
| ARKG | SURF | SURFACE ONCOLOGY | 250,000 |
| ARKG | MASS | 908 DEVICES | 52,228 |
| ARKG | SLGC | SOMALOGIC | 39,998 |
| ARKK | ZM | ZOOM VIDEO COMMUNICATIONS | 132,250 |
| ARKK | TRMB | TRIMBLE | 251,411 |
| ARKK | TWLO | TWILIO | 66,987 |
| ARKK | DNA | GINKGO BIOWORKS | 995,250 |
| ARKK | MTLS | MATERIALISE | 45,325 |
| ARKK | SGFY | SIGNIFY HEALTH | 64,300 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 100 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 315,689 |
| ARKQ | ACHR | ARCHER AVIATION | 150,906 |
| ARKQ | MKFG | MARKFORGED | 123,400 |
| ARKW | ZM | ZOOM VIDEO COMMUNICATIONS | 33,372 |
| ARKX | VLD | VELO3D | 35,426 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Source: Read Full Article
